Seegene (Korea) Performance
| 096530 Stock | KRW 23,650 550.00 2.27% |
Seegene has a performance score of 1 on a scale of 0 to 100. The entity has a beta of 0.043, which indicates not very significant fluctuations relative to the market. As returns on the market increase, Seegene's returns are expected to increase less than the market. However, during the bear market, the loss of holding Seegene is expected to be smaller as well. Seegene right now has a risk of 3.17%. Please validate Seegene mean deviation, downside deviation, standard deviation, as well as the relationship between the semi deviation and coefficient of variation , to decide if Seegene will be following its existing price patterns.
Risk-Adjusted Performance
1 of 100
Weak | Strong |
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Seegene are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Seegene is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
| Total Cashflows From Investing Activities | -102.7 B |
Seegene |
Seegene Relative Risk vs. Return Landscape
If you would invest 2,344,700 in Seegene on November 3, 2024 and sell it today you would earn a total of 20,300 from holding Seegene or generate 0.87% return on investment over 90 days. Seegene is generating 0.0622% of daily returns and assumes 3.1734% volatility on return distribution over the 90 days horizon. Simply put, 28% of stocks are less volatile than Seegene, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Seegene Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Seegene's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Seegene, and traders can use it to determine the average amount a Seegene's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0196
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | 096530 | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.17 actual daily | 28 72% of assets are more volatile |
Expected Return
| 0.06 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average Seegene is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Seegene by adding it to a well-diversified portfolio.
Seegene Fundamentals Growth
Seegene Stock prices reflect investors' perceptions of the future prospects and financial health of Seegene, and Seegene fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Seegene Stock performance.
| Return On Equity | 0.32 | |||
| Return On Asset | 0.17 | |||
| Profit Margin | 0.30 % | |||
| Operating Margin | 0.32 % | |||
| Current Valuation | 3.51 T | |||
| Shares Outstanding | 25.99 M | |||
| Price To Earning | 140.12 X | |||
| Price To Sales | 0.65 X | |||
| Revenue | 1.37 T | |||
| EBITDA | 415.89 B | |||
| Cash And Equivalents | 432.13 B | |||
| Total Debt | 102.81 B | |||
| Debt To Equity | 8.90 % | |||
| Cash Flow From Operations | 334.02 B | |||
| Total Asset | 1.49 T | |||
| Retained Earnings | 46.11 B | |||
| Current Asset | 151.8 B | |||
| Current Liabilities | 11.83 B | |||
About Seegene Performance
By analyzing Seegene's fundamental ratios, stakeholders can gain valuable insights into Seegene's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Seegene has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Seegene has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Seegene, Inc. manufactures and sells molecular diagnostics systems. Seegene, Inc. was founded in 2000 and is headquartered in Seoul, South Korea. SEEGENE is traded on Korean Securities Dealers Automated Quotations in South Korea.Things to note about Seegene performance evaluation
Checking the ongoing alerts about Seegene for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Seegene help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Seegene had very high historical volatility over the last 90 days | |
| About 31.0% of the company shares are owned by insiders or employees |
- Analyzing Seegene's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Seegene's stock is overvalued or undervalued compared to its peers.
- Examining Seegene's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Seegene's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Seegene's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Seegene's stock. These opinions can provide insight into Seegene's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Seegene Stock analysis
When running Seegene's price analysis, check to measure Seegene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Seegene is operating at the current time. Most of Seegene's value examination focuses on studying past and present price action to predict the probability of Seegene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Seegene's price. Additionally, you may evaluate how the addition of Seegene to your portfolios can decrease your overall portfolio volatility.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |